Multiple sclerosis, relapsing-remitting Clinical Trials

Delta Trials records 220 clinical trials for Multiple sclerosis, relapsing-remitting in its publicly accessible dataset. From the full dataset, 25 actively seeking eligible participants and 129 trials have reached completion. This research is conducted across 968 study locations around the world. An additional 66 trials are active but not currently open for enrollment. Since 2020, 21 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.